½ÃÀ庸°í¼­
»óǰÄÚµå
1604177

¼¼°èÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Brachy Therapy Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

±ÙÁ¢Ä¡·á ±â±â ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 15¾ï 2,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 26¾ï 9,000¸¸ ´Þ·¯ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2024-2032³âÀÇ CAGRÀº 6.52%ÀÔ´Ï´Ù.

±ÙÁ¢Ä¡·á ±â±â´Â ¾Ï Ä¡·á¸¦ À§ÇÑ ³»ºÎ ¹æ»ç¼± Ä¡·á·Î »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ¿ÜºÎ ¹æ»ç¼±°ú ´Þ¸®, ±ÙÁ¢Ä¡·á´Â ¹æ»ç¼º ¼±¿øÀ» Á¾¾ç ºÎÀ§³» ¶Ç´Â Á¾¾ç ºÎÀ§ ±Ùó¿¡ Á÷Á¢ ¹èÄ¡ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ¿¡´Â ¹æ»ç¼º ¹°ÁúÀ» Á¤È®ÇÏ°Ô ¹èÄ¡Çϱâ À§ÇÑ ´Ù¾çÇÑ ¾îÇø®ÄÉÀÌÅÍ, ½Ãµå ¹× Àü´Þ ½Ã½ºÅÛÀÌ Æ÷ÇԵ˴ϴÙ. ÁÖ¿ä ¸ñÀûÀº ÁÖº¯ °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ³ëÃâÀ» ÁÙÀ̸鼭 ³ôÀº ¹æ»ç¼±·®À» Á¾¾ç¿¡ Á÷Á¢ Á¶»çÇÏ´Â °ÍÀÔ´Ï´Ù. ±ÙÁ¢Ä¡·á´Â ÀϹÝÀûÀ¸·Î Àü¸³¼±¾Ï, ÀڱðæºÎ¾Ï, À¯¹æ¾Ï µîÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç, ¿ÜºÎ Ä¡·á¿¡ ºñÇØ ºÎÀÛ¿ëÀÌ ÀûÀ» ¼ö Àִ ǥÀûÈ­µÈ ¹æ»ç¼± Ä¡·á Á¢±Ù¹ýÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

±ÙÁ¢Ä¡·á ±â±â ½ÃÀåÀº Àü¸³¼±¾Ï, ÀڱðæºÎ¾Ï µî ±ÙÁ¢Ä¡·á·Î È¿°úÀûÀ¸·Î Ä¡·áÇÒ ¼ö ÀÖ´Â ¾ÏÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. °Ç°­ÇÑ Á¶Á÷¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÃÖ¼ÒÈ­Çϸ鼭 °í¼±·®ÀÇ ¹æ»ç¼±À» Á¾¾ç¿¡ Á¤È®ÇÏ°Ô Á¶»çÇÒ ¼ö ÀÖ´Ù´Â ÀåÁ¡Àº ±ÙÁ¢Ä¡·áÀÇ µµÀÔ È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. º¸´Ù Á¤±³ÇÑ ¹æ»ç¼± Á¶»ç ½Ã½ºÅÛÀÇ °³¹ß, ¹æ»ç¼º ¹°ÁúÀÇ °³¼± µî ±â¼ú ¹ßÀüÀ¸·Î ±ÙÁ¢Ä¡·áÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á¿Í ¸ÂÃãÇü Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ º¸´Ù ´Ù¾çÇÑ ¾ÏÁ¾¿¡ È¿°úÀûÀÎ ±ÙÁ¢Ä¡·á ±â±âÀÇ ±â¼ú Çõ½ÅÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾Ï °ËÁø ÇÁ·Î±×·¥ Áõ°¡¿Í Á¶±â ¹ß°ßÀ» À§ÇÑ ³ë·Âµµ ±ÙÁ¢Ä¡·á ´ë»ó ȯÀÚ ¼ö¸¦ Áõ°¡½ÃÄÑ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶óÀÇ È®´ë¿Í Á¾¾çÇÐ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ È®´ë´Â ½ÃÀå È®´ëÀÇ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. »õ·Î¿î ±ÙÁ¢Ä¡·á ±â¼úÀÇ °³¹ß ¹× ´Ù¸¥ Ä¡·á¹ý°úÀÇ °áÇÕÀº Ãß°¡ÀûÀÎ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ÀåºñÀÇ ³ôÀº ºñ¿ë°ú ÀáÀçÀûÀÎ ºÎÀÛ¿ëÀº ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç ¸®Æ÷Æ®´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇϰí, ¼¼°è ·¹º§¿¡¼­ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ÅøÀº ¼¼°èÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ±ÙÁ¢Ä¡·á ±â±â »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

±ÙÁ¢Ä¡·á ±â±â ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡º° ¹× Áö¿ªº° ºÎ¹®¿¡ °üÇÑ »ó¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇϰí, ÀÌ¿¡ µû¶ó Àü·«°¡°¡ ÇâÈÄ ºñÁî´Ï½º ±âȸ¿Í ÇÔ²² °¢°¢ÀÇ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ Å¸±êÃþÀ» ½Äº°Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.

Á¦Ç° À¯Çüº°

  • ±ÙÁ¢Ä¡·á ¾ÖÇÁÅͷδõ
  • ±ÙÁ¢Ä¡·á ¾ÖÇø®ÄÉÀÌÅÍ(°­³» ¾ÖÇø®ÄÉÀÌÅÍ, °£Áú ¾ÖÇø®ÄÉÀÌÅÍ, ±âŸ)
  • ±âŸ

¼±·®·üº°

  • °í¼±·®·ü(HDR) ±ÙÁ¢Ä¡·á
  • Àú¼±·®·ü(LDR) ±ÙÁ¢Ä¡·á
  • ÆÞ½º ¼±·®·ü(PDR) ±ÙÁ¢Ä¡·á

ÀûÀÀÁõº°

  • Àü¸³¼±¾Ï
  • À¯¹æ¾Ï
  • ÀڱðæºÎ¾Ï
  • ÇǺξÏ
  • ±âŸ

ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ¾ÏÄ¡·á ¼¾ÅÍ
  • ±âŸ

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀåÀÇ ÇöÀç ¹× ÇâÈÄ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤¡¤¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. Value Market ResearchÀÇ Á¶»çÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü ¸®Æ÷Æ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå ±ÙÁ¢Ä¡·á ±â±â - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

  • °³¿ä
  • °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ±ÙÁ¢Ä¡·á ¾ÖÇÁÅͷδõ
  • ±ÙÁ¢Ä¡·á¿ë ¾ÖÇø®ÄÉÀÌÅÍ(°­³» ¾ÖÇø®ÄÉÀÌÅÍ, °£Áú ¾ÖÇø®ÄÉÀÌÅÍ, ±âŸ)
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå ºÐ¼® : ¼±·®·üº°

  • °³¿ä
  • °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • °í¼±·®·ü(HDR) ±ÙÁ¢Ä¡·á
  • Àú¼±·®·ü(LDR) ±ÙÁ¢Ä¡·á
  • ÆÞ½º ¼±·®·ü(PDR) ±ÙÁ¢Ä¡·á

Á¦7Àå ¼¼°èÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

  • °³¿ä
  • °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • Àü¸³¼±¾Ï
  • À¯¹æ¾Ï
  • ÀڱðæºÎ¾Ï
  • ÇǺξÏ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
  • °ú°Å¡¤¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • º´¿ø
  • ¾ÏÄ¡·á ¼¾ÅÍ
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ±ÙÁ¢Ä¡·á ±â±â ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì ºÎ¹®º°
    • ºÏ¹Ì ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ ºÎ¹®º°
    • À¯·´ ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º° ¸®½ºÆ®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ±ÙÁ¢Ä¡·á ±â±â Á¦Á¶¾÷üÀÇ °æÀï»óȲ

  • ±ÙÁ¢Ä¡·á ±â±â ½ÃÀåÀÇ °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦11Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Boston Scientific Corporation
  • BD
  • Civco Medical Solutions
  • Cook
  • Bebig Medical GmbH
  • Elekta
  • Theragenics Corporation
  • Varian Medical Systems Inc. ICAD Inc
KSA 24.12.12

The global demand for Brachy Therapy Devices Market is presumed to reach the market size of nearly USD 2.69 Billion by 2032 from USD 1.52 Billion in 2023 with a CAGR of 6.52% under the study period 2024-2032.

Brachy therapy devices are medical instruments used as internal radiation therapy for cancer treatment. Unlike external beam radiation, brachytherapy involves placing radioactive sources directly within or close to the tumor site. These devices include a variety of applicators, seeds, and delivery systems that ensure the precise placement of radioactive materials. The main objective is to administer high radiation levels directly to the tumor while reducing exposure to the surrounding healthy tissues. Brachytherapy is commonly used in the treatment of cancers such as prostate, cervical, and breast cancer, offering a targeted approach to radiation therapy with potentially fewer side effects compared to external treatments.

MARKET DYNAMICS

The brachy therapy devices market is expanding due to the growing incidence of cancers that are effectively treated with brachytherapy, such as prostate and cervical cancers. The advantages of brachytherapy, including its ability to deliver high-dose radiation precisely to the tumor with minimal impact on healthy tissue, drive increased adoption. Technological advancements, such as the development of more sophisticated delivery systems and improved radioactive materials, are enhancing the efficacy and safety of brachytherapy. Additionally, the rising focus on personalized medicine and tailored treatment approaches fosters innovation in brachytherapy devices, making them more effective for a broader range of cancer types. The rise in cancer screening programs and early detection efforts also contributes to brachy therapy device market growth by increasing the number of patients eligible for brachytherapy. Furthermore, expanding healthcare infrastructure and growing investments in oncology research and development are creating opportunities for market expansion. The development of new brachytherapy techniques and combinations with other therapies presents additional growth opportunities. However, the high costs of devices and potential side effects can restrain the growth of brachy therapy devices in the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Brachy Therapy Devices. The growth and trends of Brachy Therapy Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Brachy Therapy Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Brachytherapy Afterloaders
  • Brachytherapy Applicators (Intracavitary Applicators, Interstitial Applicators, Others)
  • Others

By Dose Rate

  • High Dose Rate (HDR) Brachytherapy
  • Low Dose Rate (LDR) Brachytherapy
  • Pulse Dose Rate (PDR) Brachytherapy

By Indication

  • Prostate Cancer
  • Breast Cancer
  • Cervical Cancer
  • Skin Cancer
  • Others

By End-user

  • Hospitals
  • Cancer Treatment Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Brachy Therapy Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Brachy Therapy Devices market include Boston Scientific Corporation, BD, Civco Medical Solutions, Cook, Bebig Medical GmbH, Elekta, Theragenics Corporation, Varian Medical Systems Inc. ICAD Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BRACHY THERAPY DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Dose Rate
    • 3.7.3 Market Attractiveness Analysis By Indication
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BRACHY THERAPY DEVICES MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Brachytherapy Afterloaders Historic and Forecast Sales By Regions
  • 5.4. Brachytherapy Applicators (Intracavitary Applicators, Interstitial Applicators, Others) Historic and Forecast Sales By Regions
  • 5.5. Others Historic and Forecast Sales By Regions

6. GLOBAL BRACHY THERAPY DEVICES MARKET ANALYSIS BY DOSE RATE

  • 6.1. Overview By Dose Rate
  • 6.2. Historical and Forecast Data Analysis By Dose Rate
  • 6.3. High Dose Rate (HDR) Brachytherapy Historic and Forecast Sales By Regions
  • 6.4. Low Dose Rate (LDR) Brachytherapy Historic and Forecast Sales By Regions
  • 6.5. Pulse Dose Rate (PDR) Brachytherapy Historic and Forecast Sales By Regions

7. GLOBAL BRACHY THERAPY DEVICES MARKET ANALYSIS BY INDICATION

  • 7.1. Overview By Indication
  • 7.2. Historical and Forecast Data Analysis By Indication
  • 7.3. Prostate Cancer Historic and Forecast Sales By Regions
  • 7.4. Breast Cancer Historic and Forecast Sales By Regions
  • 7.5. Cervical Cancer Historic and Forecast Sales By Regions
  • 7.6. Skin Cancer Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL BRACHY THERAPY DEVICES MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-user
  • 8.2. Historical and Forecast Data Analysis By End-user
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Cancer Treatment Centers Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL BRACHY THERAPY DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BRACHY THERAPY DEVICES COMPANIES

  • 10.1. Brachy Therapy Devices Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF BRACHY THERAPY DEVICES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Boston Scientific Corporation
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. BD
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Civco Medical Solutions
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Cook
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Bebig Medical GmbH
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Elekta
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Theragenics Corporation
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Varian Medical Systems Inc. ICAD Inc
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦